The aim of this study was to compare the efficacy of suprascapular nerve block plus physical therapy (PT) with PT alone for the treatment of adhesive capsulitis of the shoulder.
Forty-one patients with adhesive capsulitis were randomly assigned to the injection group (n = 19) or PT-alone control group (n = 22). All patients received PT consisting of electrotherapy, range of motion, stretching, and strengthening exercises. The patients in the injection group received suprascapular nerve block before PT. Pain was assessed using the Brief Pain Inventory-Short Form, and functional status was assessed with the total Constant score.
In both groups, significant differences were found in all parameters of the Brief Pain Inventory-Short Form compared with baseline levels apart from walking ability in the last 24 hrs (P = not applicable). However, the differences of mean pain severity in the last 24 hrs at first to second and first to third assessments, pain severity at that time at first to second assessments, percentage improvement at second to third assessments, general activity in the last 24 hrs at first to second and first to third assessments, and enjoyment of life in the last 24 hrs at first to second and first to third assessments were statistically significant in favor of the injection group (P < 0.05).
The current study supports that suprascapular nerve block is a safe and well-tolerated method. PT was found to be effective in reducing pain severity and functional disability, and the addition of suprascapular nerve block to PT improved functional status and pain levels in patients with adhesive capsulitis.
From the Department of Physical Medicine and Rehabilitation, Atatürk State Hospital, Antalya, Turkey (ZK); and Department of Physical Medicine and Rehabilitation, Antalya Training and Research Hospital, Antalya, Turkey (MBF, TÇ, NFT).
All correspondence and requests for reprints should be addressed to: Meral Bilgilisoy Filiz, MD, Department of Physical Medicine and Rehabilitation, Antalya Training and Research Hospital, Varlık Mahallesi, Kazım Karabekir Caddesi Soğuksu 07100, Antalya, Turkey.
Zeynep Kılıç and Meral Bilgilisoy Filiz contributed equally to this work.
The project had no financial support.
This study was presented as an abstract at the “Annual European Congress of Rheumatology EULAR 2014, Paris, France, 11–14 June 2014” with the submission number EULAR14-SCIE-2278.
Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.